Compound Summary
Denopamine
Compound Information
Denopamine
Compound Name: | Denopamine |
Compound CID: | 5311064 |
Synonyms: | Denopamine 71771-90-9 R(-)-Denopamine Kalgut UNII-V5F60UPD8P More... |
Iupac Name: | 4-[(1R)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol |
InChI: | InChI=1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1 |
InChIKey: | VHSBBVZJABQOSG-INIZCTEOSA-N |
Canonical Smiles: | COC1=C(C=C(C=C1)CCNCC(C2=CC=C(C=C2)O)O)OC |
Isomeric Smiles: | COC1=C(C=C(C=C1)CCNC[C@@H](C2=CC=C(C=C2)O)O)OC |
Molecular Weight: | 317.4 |
Molecular Formula: | C18H23NO4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Denopamine
Molecular Weight: | 317.4 |
Molecular Formula: | C18H23NO4 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 23 |
Complexity: | 320 |
Synonyms
Denopamine
| Denopamine | Denopamine |
|---|---|
Denopamine |
71771-90-9 |
R(-)-Denopamine |
Kalgut |
UNII-V5F60UPD8P |
TA 064 |
TA-064 |
4-(1R)-2-2-(3,4-dimethoxyphenyl)ethylamino-1-hydroxyethylphenol |
V5F60UPD8P |
CHEMBL493682 |
Denopamina |
Denopaminum |
4-(1R)-2-2-(3,4-Dimethoxyphenyl)ethylamino-1-hydroxy-ethylphenol |
Benzenemethanol, a-2-(3,4-dimethoxyphenyl)ethylaminomethyl-4-hydroxy-,(aR)- |
Denopaminum Latin |
Kalgut (TN) |
Denopamina Spanish |
Denopamine INN:JAN |
R()-Denopamine |
NCGC00094384-01 |
Denopamine (JAN/INN) |
Lopac-D-7815 |
DSSTox_CID_25800 |
DSSTox_RID_81138 |
DSSTox_GSID_45800 |
GTPL534 |
SCHEMBL218640 |
DTXSID8045800 |
CHEBI:135359 |
BCP17423 |
ZINC1552175 |
Tox21_111272 |
BDBM50252956 |
MFCD00867122 |
(-)-(R)-1-(p-Hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol |
Benzenemethanol, alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (R)- |
NCGC00015367-01 |
K215 |
CAS-71771-90-9 |
R(-)-Denopamine, >=98% (HPLC), powder |
D02614 |
Dimethoxyphenyl)ethylamino-1-hydroxyethylphenol |
(R)-4-(2-(3,4-dimethoxyphenethylamino)-1-hydroxyethyl)phenol |
4-(1R)-2-2-(3,4- |
(-)-alpha-(3,4-Dimethoxyphenethylaminomethyl)-4-hydroxy-benzyl-alcohol |
4-(1R)-2-{2-(3,4-dimethoxyphenyl)ethylamino}-1-hydroxyethylphenol |
(-)-(R)-alpha-(((3,4-Dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl alcohol |
Experimental Data
Denopamine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -6.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Denopamine
Statistics Data
Denopamine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -6.000000000000000 | 1 | 1 |
Statistics Data Visualization
Denopamine
